BioCentury
ARTICLE | Company News

Almac, Genentech, Roche deal

June 22, 2015 7:00 AM UTC

Almac’s Almac Discovery oncology subsidiary granted Roche’s Genentech unit exclusive, worldwide rights to develop and commercialize a preclinical ubiquitin-specific protease inhibitor. Genentech plans...